<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl2">
 <label>Table 2</label>
 <caption>
  <p>Demographic and clinical characteristics of cases without HIV infection and controls for all sites</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th/>
    <th/>
    <th align="left">
     <bold>All cases</bold>
    </th>
    <th align="left">
     <bold>Cases with a positive x-ray</bold>
    </th>
    <th align="left">
     <bold>Controls</bold>
    </th>
    <th align="left">
     <bold>p value</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="3" align="left">Total</td>
    <td align="left">3981</td>
    <td align="left">1769</td>
    <td align="left">5102</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Age, months</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">28 days–5</td>
    <td align="left">1619 (40·7%)</td>
    <td align="left">691 (39·1%)</td>
    <td align="left">1598 (31·3%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">6–11</td>
    <td align="left">908 (22·8%)</td>
    <td align="left">425 (24·0%)</td>
    <td align="left">1210 (23·7%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">12–23</td>
    <td align="left">903 (22·7%)</td>
    <td align="left">436 (24·6%)</td>
    <td align="left">1262 (24·7%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">24–59</td>
    <td align="left">551 (13·8%)</td>
    <td align="left">217 (12·3%)</td>
    <td align="left">1032 (20·2%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="7" align="left">Sex</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Girls</td>
    <td align="left">1684 (42·3%)</td>
    <td align="left">778 (44·0%)</td>
    <td align="left">2533 (49·7%)</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Respiratory tract illness (controls only)</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">1206 (23·6%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Positive malaria smear
     <xref rid="tbl2fn1" ref-type="table-fn">*</xref>
    </td>
    <td align="left">91 (3·9%)</td>
    <td align="left">19 (1·9%)</td>
    <td align="left">35 (1·3%)</td>
    <td align="left">0·1480</td>
   </tr>
   <tr>
    <td colspan="7" align="left">DTP vaccine</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Number of doses (regardless of age)</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">0</td>
    <td align="left">480 (12·5%)</td>
    <td align="left">201 (11·8%)</td>
    <td align="left">249 (5·0%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">1–2</td>
    <td align="left">1086 (28·3%)</td>
    <td align="left">484 (28·4%)</td>
    <td align="left">1060 (21·1%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">≥3</td>
    <td align="left">2267 (59·1%)</td>
    <td align="left">1017 (60·0%)</td>
    <td align="left">3708 (73·9%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="6" align="left">Fully vaccinated for age
     <xref rid="tbl2fn2" ref-type="table-fn">†</xref>
    </td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">Age &lt;1 year</td>
    <td align="left">1724 (70·3%)</td>
    <td align="left">751 (69·5%)</td>
    <td align="left">2258 (81·0%)</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">Age ≥ 1 year</td>
    <td align="left">1264 (91·5%)</td>
    <td align="left">566 (91·1%)</td>
    <td align="left">2083 (93·5%)</td>
    <td align="left">0·1407</td>
   </tr>
   <tr>
    <td colspan="7" align="left">PCV</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Number of doses (regardless of age)</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">0·0014</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">0</td>
    <td align="left">1690 (43·8%)</td>
    <td align="left">701 (40·8%)</td>
    <td align="left">2404 (47·9%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">1–2</td>
    <td align="left">1021 (26·4%)</td>
    <td align="left">480 (28·0%)</td>
    <td align="left">1056 (21·0%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">≥3</td>
    <td align="left">1151 (29·8%)</td>
    <td align="left">536 (31·2%)</td>
    <td align="left">1561 (31·1%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="6" align="left">Fully vaccinated for age
     <xref rid="tbl2fn3" ref-type="table-fn">‡</xref>
    </td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">Age &lt;1 year</td>
    <td align="left">1226 (49·7%)</td>
    <td align="left">566 (52·0%)</td>
    <td align="left">1384 (49·6%)</td>
    <td align="left">0·0004</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">Age ≥1 year</td>
    <td align="left">640 (45·9%)</td>
    <td align="left">291 (46·3%)</td>
    <td align="left">867 (38·8%)</td>
    <td align="left">0·7019</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Full vaccination for measles
     <xref rid="tbl2fn4" ref-type="table-fn">§</xref>
    </td>
    <td align="left">1453 (86·8%)</td>
    <td align="left">646 (85·3%)</td>
    <td align="left">2459 (90·6%)</td>
    <td align="left">0·0135</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Mid-upper arm circumference &lt;11·5 cm
     <xref rid="tbl2fn5" ref-type="table-fn">¶</xref>
    </td>
    <td align="left">171 (7·4%)</td>
    <td align="left">93 (8·8%)</td>
    <td align="left">29 (0·8%)</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Weight-for-age Z score</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Severe (&lt; −3)</td>
    <td align="left">631 (15·9%)</td>
    <td align="left">338 (19·2%)</td>
    <td align="left">196 (3·9%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Moderate (≥ −3 to &lt; −2)</td>
    <td align="left">754 (19·0%)</td>
    <td align="left">361 (20·5%)</td>
    <td align="left">515 (10·1%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Normal (≥ −2)</td>
    <td align="left">2584 (65·1%)</td>
    <td align="left">1062 (60·3%)</td>
    <td align="left">4368 (86·0%)</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Antibiotic activity detected in serum</td>
    <td align="left">918 (24·5%)</td>
    <td align="left">425 (25·3%)</td>
    <td align="left">85 (1·8%)</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Previous exposure to antibiotics
     <xref rid="tbl2fn6" ref-type="table-fn">‖</xref>
    </td>
    <td align="left">1530 (38·9%)</td>
    <td align="left">704 (40·1%)</td>
    <td align="left">85 (1·7%)</td>
    <td align="left">&lt;0·0001</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Median duration of illness (days)</td>
    <td align="left">3·0 (2·0–5·0)</td>
    <td align="left">3·0 (2·0–5·0)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Very severe pneumonia</td>
    <td align="left">1279 (32·1%)</td>
    <td align="left">519 (29·3%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Wheeze on auscultation</td>
    <td align="left">1340 (33·9%)</td>
    <td align="left">555 (31·7%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Tachypnoea</td>
    <td align="left">3256 (82·4%)</td>
    <td align="left">1492 (85·3%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Hypoxaemia</td>
    <td align="left">1423 (35·8%)</td>
    <td align="left">748 (42·3%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Oxygen use at admission
     <xref rid="tbl2fn7" ref-type="table-fn">**</xref>
    </td>
    <td align="left">1243 (37·4%)</td>
    <td align="left">671 (43·9%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Temperature ≥38·0°C</td>
    <td align="left">1213 (30·5%)</td>
    <td align="left">591 (33·5%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">CRP ≥40 mg/L</td>
    <td align="left">925 (27·6%)</td>
    <td align="left">526 (34·9%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Elevated WBC count</td>
    <td align="left">1620 (43·4%)</td>
    <td align="left">793 (47·8%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="7" align="left">Chest x-ray findings</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Positive</td>
    <td align="left">1769 (44·4%)</td>
    <td align="left">1769 (100%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">Consolidation</td>
    <td align="left">841 (21·1%)</td>
    <td align="left">841 (47·5%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td/>
    <td align="left">Other infiltrate</td>
    <td align="left">928 (23·3%)</td>
    <td align="left">928 (52·5%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Negative</td>
    <td align="left">1627 (40·9%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Uninterpretable</td>
    <td align="left">351 (8·8%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Missing</td>
    <td align="left">234 (5·9%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="7" align="left">Blood culture volume, mL
     <xref rid="tbl2fn8" ref-type="table-fn">††</xref>
    </td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">1 to &lt;2</td>
    <td align="left">1649 (48·7%)</td>
    <td align="left">753 (51·4%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">≥2 to &lt;3</td>
    <td align="left">1313 (38·8%)</td>
    <td align="left">537 (36·7%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">≥3</td>
    <td align="left">425 (12·6%)</td>
    <td align="left">175 (12·0%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Died in hospital or within 30 days of admission</td>
    <td align="left">292 (7·3%)</td>
    <td align="left">114 (6·4%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Died in hospital</td>
    <td align="left">251 (6·3%)</td>
    <td align="left">95 (5·4%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td/>
    <td colspan="2" align="left">Died post discharge, within 30 days of admission
     <xref rid="tbl2fn9" ref-type="table-fn">‡‡</xref>
    </td>
    <td align="left">41 (1·0%)</td>
    <td align="left">19 (1·1%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
   <tr>
    <td colspan="3" align="left">Missing 30-day vital status</td>
    <td align="left">346 (8·7%)</td>
    <td align="left">146 (8·3%)</td>
    <td align="left">..</td>
    <td align="left">..</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Data are n (%) or median (IQR). Positive cases are those with a positive chest x-ray. p values obtained from logistic regression models adjusted for age in months (all variables expect age category) and site for cases with a positive x-ray versus controls. During the study, pneumococcal conjugate vaccine (PCV) was in routine use in Kenya (introduced February, 2011), The Gambia (August, 2009), Mali (March, 2011), and South Africa (April, 2009); PCV was introduced in Zambia in July, 2013 (Lusaka), 3 months before the end of study enrolment. Duration of illness was defined as duration (in days) of cough, wheeze, fever, or difficulty breathing, whichever was longest. Tachypnoea was defined as 60 or more breaths per min (&lt;2 months), 50 or more breaths per min (2–11 months), and 40 or more breaths per min (12–59 months). Hypoxaemia was defined as oxygen saturation lower than 92% (or &lt;90% for sites at elevation above 1200 m: Zambia and South Africa), or supplemental oxygen use if a room air oxygen saturation reading was not available; a room air oxygen saturation reading was available for 3514 (88·3%) children; the South African site, at an altitude of 1600 m above sea level, had a standard clinical practice to administer supplemental oxygen for all children admitted to hospital with a diagnosis of severe pneumonia. Elevated white blood cell (WBC) count was defined as greater than 15 × 109 cells per L for children aged 1–11 months and greater than 13 × 109 cells per L for children aged 12–59 months. CRP=C-reactive protein.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn1">
   <label>*</label>
   <p id="cenpara50">Restricted to endemic sites (Kenya, Gambia, Mali, and Zambia).</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn2">
   <label>†</label>
   <p id="cenpara60">For children younger than 1 year, full vaccination was defined as having received at least one dose and being up to date for age on the basis of the child's age at enrolment, doses received, and country schedule (allowing a 4-week window for each dose); for children aged 1 year or older, full vaccination was defined as having received three or more doses.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn3">
   <label>‡</label>
   <p id="cenpara70">For children younger than 1 year, full vaccination was defined as having received at least one dose and being up to date for age on the basis of the child's age at enrolment, doses received, and country schedule (allowing a 4-week window for each dose); for children aged 1 year or older in all sites except Kenya, full vaccination was defined as having received three or more doses; for children older than 1 year in Kenya (which introduced PCV with catch-up campaign), full vaccination was defined as having received three or more doses, two doses if given at least 8 weeks apart and the child was older than 1 year of age at first dose, and one dose if the child was older than 2 years at any dose or at introduction.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn4">
   <label>§</label>
   <p id="cenpara80">Data restricted to those age-eligible; at least one dose was restricted to children older than 10 months (&gt;10·5 months in Bangladesh).</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn5">
   <label>¶</label>
   <p id="cenpara90">Restricted to children aged 6 months or older.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn6">
   <label>‖</label>
   <p id="cenpara100">Defined as serum bioassay positive (cases and controls), antibiotics administered at the referral facility, or antibiotic administration before the collection of whole blood specimens at the study facility (cases only); restricted to children with blood culture (cases only) or whole blood (cases or controls) collected.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn7">
   <label>**</label>
   <p id="cenpara110">Data was recorded in the Mali site on the basis of time at presentation, not time at admission, as was done at all other sites; Mali is excluded from the all site summary.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn8">
   <label>††</label>
   <p id="cenpara120">13·7% of cases with a blood culture collected were missing blood culture volume data.
    <xref rid="bib29" ref-type="bibr">
     <sup>29</sup>
    </xref>
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl2fn9">
   <label>‡‡</label>
   <p id="cenpara130">Restricted to children discharged alive who had vital status data obtained 21 days or longer after admission.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
